Charity urges greater focus on hepatitis B to match hepatitis C progress on World Hepatitis Day

July 28, 2023

On this World Hepatitis Day, the British Liver Trust unites with the World Hepatitis Alliance and its global network to accelerate the fight against viral hepatitis, which claims a life every 30 seconds globally and calls for urgent action in the UK to address the pressing issue of hepatitis B, a significant risk factor for liver cancer.

A recent World Hepatitis Alliance survey revealed that 42% of people globally are unaware of viral hepatitis as a leading cause of liver cancer. Increased awareness can drive testing and vaccination rates, helping combat this preventable and treatable disease. The report also reveals that individuals living with hepatitis B and C face a “similar or significantly higher risk of developing cancer than someone who actively smokes one pack of cigarettes per day.” Consequently, there are calls for hepatitis B and hepatitis C to be “considered as cancer-causing infections,” urging a revision of international guidelines accordingly.

In the UK, as a result of increased testing and curative treatments, the nation is currently on track to achieve the 2030 elimination goal set by the World Health Organization for hepatitis C. Between 2015 and 2021, there was a 47% decline in hepatitis C cases[i], while it is estimated that only 19% of those affected by hepatitis B in the UK[ii] have received a proper diagnosis.

Vanessa Hebditch, Director of Policy at the British Liver Trust, says: “With more than 200,000[iii] people in the UK affected, with the majority unaware of their condition, shining a spotlight on hepatitis B becomes essential to achieve the same progress made in combating hepatitis C.

“Currently, there is no absolute cure for hepatitis B, but effective treatments can reduce the risk of the virus developing into a more serious liver condition.”

Most people living with hepatitis B in the UK were born in a country where the virus is more common and acquired it there either at birth or as a child. Individuals are also at risk of contracting the virus through any type of sex without a condom or getting a tattoo or piercing with unsterilised equipment.

Vanessa continues: “Both hepatitis B and hepatitis C usually have no symptoms in the early stages, so it is vital to get tested if you have ever been exposed. To find out if you are at risk, take the British Liver Trust’s simple questionnaire.”

Living with Hepatitis B often subjects individuals to daily stigma. False beliefs about hepatitis B persist among both those with and without the infection.

Amanda, who was diagnosed with Hepatitis B in 2019, says: “I’d never heard of Hepatitis B until I was diagnosed, and it was a really, really dark time for me. What worries me is that so many other people are stuck in that darkness too. The important thing to remember is that it can affect anyone, and more than anything I want people to get tested. If I didn’t know I had it and was symptom-free, how many more people are out there living with the infection?  I would also tell people not to self-stigmatise and to talk about it.”

To improve detection rates, the UK Government included a blood test for Hepatitis B in its opt out testing pilot for blood-borne viruses in emergency departments. The first year of the scheme has identified more than triple the number of people living with Hepatitis B (1,186) than HIV (465)[1]. Yet there is no commitment to scale up screening and treatment in areas with the highest prevalence of Hepatitis B.

The British Liver Trust urges the public, healthcare professionals and policymakers to unite in the fight against hepatitis B by raising awareness, tackling stigma, improving testing and diagnosis rates and expanding access to treatment and care.

______________________________________________

British LIver Trust hepatitis B pages – Hepatitis B – British Liver Trust

[1] https://www.gov.uk/government/publications/hiv-action-plan-annual-update-to-parliament/hiv-action-plan-annual-update-to-parliament#annex-a-bbv-opt-out-testing-in-emergency-departments-2022-to-2023-by-nhse

[i] https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1133731/hepatitis-c-in-the-UK-2023.pdf

[ii] Countries Dashboard – CDA Foundation

[iii] Hepatitis B in England – 2023 report (publishing.service.gov.uk)

 

More news

Our Budget Case to the Treasury: Investing in Prevention

Our Budget Case to the Treasury: Investing in Prevention

The Autumn Budget on 28th October is a chance to prevent thousands of families from experiencing the devastating impact of liver disease. Because 90% of liver disease is preventable, government action on alcohol harm and obesity could ...
Liver UK helps shape new European recommendations on liver cancer surveillance

Liver UK helps shape new European recommendations on liver cancer surveillance

A major new paper published in The Lancet Regional Health – Europe has highlighted the challenges of detecting liver cancer earlier across Europe and sets out practical lessons from countries around the world to improve surveillance ...
The LIVERAGE research studies

The LIVERAGE research studies

The LIVERAGE and LIVERAGE Cirrhosis studies are large clinical research studies for adults living with MASLD, a type of fatty liver disease. These studies focus on people with MASH, a more advanced form of MASLD.  The studies include ...
No results found.
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.